MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
Top Ranked Value Stocks to Buy for December 11th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 11th:
AIG Slips to 52 Week Low: Will the Stock Decline Further?
by Zacks Equity Research
Shares of American International Group (AIG) hit a 52-week low on Dec 7 due to its catastrophe loss forecast and weak revenues.
Top Ranked Value Stocks to Buy for December 7th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 7th
Zacks.com featured highlights include: MetLife, Echo Global, Gulfport, Barclays and CAI
by Zacks Equity Research
Zacks.com featured highlights include: MetLife, Echo Global, Gulfport, Barclays and CAI
6 Low Price-to-Book Value Stocks to Buy in December
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
6 Solid Reasons to Invest in MetLife for Portfolio Growth
by Zacks Equity Research
Backed by a solid capital management and business rejig, MetLife (MET) holds great prospects to reap returns for investors.
Why Is MetLife (MET) Up 6.4% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
American International's (AIG) New Subsidiaries Get Ratings
by Zacks Equity Research
American International's (AIG) units receive rating actions from Moody's. The rating outlook remains stable.
Zacks.com featured highlights include: Metlife, Capital One, Rocky, Koninklijke, Delhaize and Verso
by Zacks Equity Research
Zacks.com featured highlights include: Metlife, Capital One, Rocky, Koninklijke, Delhaize and Verso
Forget AIG, Buy These Insurance Stocks Instead
by Sapna Bagaria
While the stock of AIG is weighed down by the company's headwinds, other stocks in the industry look attractive.
W.R. Berkley (WRB) Continues to Benefit From Premium Growth
by Zacks Equity Research
W.R. Berkley (WRB) consistently gains from higher premiums and better investment results.
7 Low Price-to-Sales Stocks to Strengthen Your Portfolio
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
6 Solid Reasons to Hold Aon (AON) Stock in Your Portfolio
by Zacks Equity Research
Banking on solid results, strategic initiatives and a strong financial position, Aon (AON) promises to reap favorable returns for investors.
7 Solid Reasons Why Cigna is a Must Add to Your Portfolio
by Zacks Equity Research
Backed by a solid third-quarter performance, strong Global Healthcare segment and burgeoning membership, Cigna (CI) holds great potential for yield-seeking investors.
Zacks Value Trader Highlights: BP, Walgreens, Sony, MetLife and PACCAR
by Zacks Equity Research
Zacks Value Trader Highlights: BP, Walgreens, Sony, MetLife and PACCAR
Looking for Value? Why It Might Be Time to Try MetLife (MET)
by Zacks Equity Research
MetLife (MET) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
5 Cheap Large Cap Stocks to Buy Now
by Tracey Ryniec
Don't be scared about the stock market sell off, look for big cap deals instead.
RLI Benefits From Premium Growth, Rising Costs a Concern
by Zacks Equity Research
RLI continues to gain from consistent premium growth, better investment results and a strong capital position. However, exposure to cat loss and rising expenses are spoilers.
Brown & Brown (BRO) Unit Buyout to Enrich Service Portfolio
by Zacks Equity Research
Brown & Brown (BRO) arm buys Rodman Insurance, which is anticipated to add substance to the company's service portfolio via a comprehensive suite of P&C insurance products and services.
Assurant (AIZ) Rewards Shareholders With 7% Dividend Hike
by Zacks Equity Research
Assurant (AIZ) instills investors' confidence in the stock with a dividend increase of 7%.
The Zacks Analyst Blog Highlights: ExxonMobil, Occidental Petroleum, General Motors, MetLife and Digital Realty Trust
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Occidental Petroleum, General Motors, MetLife and Digital Realty Trust
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Research Reports for ExxonMobil, Occidental Petroleum & General Motors
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Occidental Petroleum (OXY) and General Motors (GM).
Company News For Nov 2, 2018
by Zacks Equity Research
Companies In The News Are: W,MSI,MET,PGTI
MetLife (MET) Q3 Earnings Top Estimates on Volume Growth
by Zacks Equity Research
MetLife (MET) Q3 encourages with volume growth, favorable underwriting, expense management and an improved investment income.